SCHEMBL6972959

SCHEMBL6972959

Cc1ccc(C(=O)NCC2CCN(CC3COc4ccc(Cl)cc4O3)CC2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 2/20 0.47
ADRA1A P35348 2/20 0.47
ADRA1B P35368 2/20 0.47
DRD2 P14416 2/20 0.47
HTR1A P08908 1/20 0.47
DRD4 P21917 1/20 0.47
HTR2C P28335 1/20 0.47
DRD3 P35462 1/20 0.47
NPC1 O15118 1/20 0.46
TSHR P16473 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
CACNA1I Q9P0X4 3/20 0.44
KCNH2 Q12809 2/20 0.43
CA2 P00918 1/20 0.42
MCHR1 Q99705 1/20 0.42
F10 P00742 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976892 0.88 ADRA2A (0.58) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL8382829 0.88 ADRA2A (0.58) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL6980394 0.87 NPC1 (0.45) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL8382610 0.87 NPC1 (0.45) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL8386689 0.84 ADRA1D (0.50) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL6977805 0.84 ADRA1D (0.50) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL8383034 0.84 ADRA1D (0.46) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL6981556 0.84 ADRA1D (0.46) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL6980314 0.83 CACNA1I (0.53) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL8386721 0.83 CACNA1I (0.53) ADRA1DADRA1AADRA1BDRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP claimed
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed